Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CARDINAL HEALTH INCCAH · Entity 3014 | CEO, PSS Segment | August 18, 2026 | August 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CARDINAL HEALTH INC
Report date August 18, 2026 · Filed August 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 77,901 |
Ending reported balance
After 2026-08-18 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-08-18 · Sale · Disposed 6,665 · Balance 78,590 F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.17 to $236.02, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 2, and 3 to this Form 4. Row 2 · 2026-08-18 · Sale · Disposed 408 · Balance 78,182 F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.24 to $237.143, inclusive. Row 3 · 2026-08-18 · Sale · Disposed 281 · Balance 77,901 F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.2615 to $237.6285, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.17 to $236.02, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 2, and 3 to this Form 4.
F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.24 to $237.143, inclusive.
F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.2615 to $237.6285, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 18, 2026 Filed Aug 20, 2026 11:30 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 281 | $237.44 | $66,720.64 |
DisclosureSEC source: 0001942639-26-000003 · wk-form4_1787225409.xml · nonDerivative · entry 3 WEITZMAN DEBORAH · CIK 0001942639 · CEO, PSS Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,901 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.2615 to $237.6285, inclusive. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 11:30 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 408 | $236.59 | $96,528.72 |
DisclosureSEC source: 0001942639-26-000003 · wk-form4_1787225409.xml · nonDerivative · entry 2 WEITZMAN DEBORAH · CIK 0001942639 · CEO, PSS Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,182 F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.24 to $237.143, inclusive. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 11:30 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 6,665 | $235.30 | $1,568,274.50 |
DisclosureSEC source: 0001942639-26-000003 · wk-form4_1787225409.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, PSS Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,590 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.17 to $236.02, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 2, and 3 to this Form 4. Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:15 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 29,759 | $235.17 | $6,998,424.03 |
DisclosureSEC source: 0001942639-26-000002 · wk-form4_1787084107.xml · nonDerivative · entry 2 WEITZMAN DEBORAH · CIK 0001942639 · CEO, PSS Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,255 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 12,661 RSUs and 54,823 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:15 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 7,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001942639-26-000002 · wk-form4_1787084107.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, PSS Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,014 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2027. Read SEC document |
| August 04, 2026 Filed Aug 6, 2026 10:04 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 54,823 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-26-000030 · wk-form4_1786010651.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, PSS Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,700 F1 · kind: Reflects performance share units that will settle on August 15, 2026. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 21:11 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 551 | $212.26 | $116,955.26 |
DisclosureSEC source: 0001942639-25-000005 · wk-form4_1764709892.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, PSS Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,877 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units. F2 · price: Price is closing share price on prior business day. Read SEC document |
| August 20, 2025 Filed Aug 20, 2025 20:12 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 21,367 | $150.53 | $3,216,374.51 |
DisclosureSEC source: 0000721371-25-000101 · wk-form4_1755720759.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, PSS Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,428 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.22 to $151.00, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 23:20 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 24,128 | $150.22 | $3,624,508.16 |
DisclosureSEC source: 0000721371-25-000096 · wk-form4_1755645616.xml · nonDerivative · entry 2 WEITZMAN DEBORAH · CIK 0001942639 · CEO, PSS Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,795 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 14,966 RSUs and 39,100 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 23:20 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 10,694 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-25-000096 · wk-form4_1755645616.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, PSS Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,923 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2026. Read SEC document |
| August 12, 2025 Filed Aug 12, 2025 20:19 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 39,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-25-000088 · wk-form4_1755029940.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, PSS Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,229 F1 · kind: Reflects performance share units that will settle on August 15, 2025. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:18 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 632 | $122.24 | $77,255.68 |
DisclosureSEC source: 0000721371-24-000166 · wk-form4_1733260712.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, PSS Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,129 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 00:15 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 2,341 | $107.91 | $252,617.31 |
DisclosureSEC source: 0000721371-24-000073 · wk-form4_1724112931.xml · nonDerivative · entry 3 WEITZMAN DEBORAH · CIK 0001942639 · CEO, PSS Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,761 F4 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 5,162 RSUs. F2 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:15 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 13,530 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-24-000073 · wk-form4_1724112931.xml · nonDerivative · entry 2 WEITZMAN DEBORAH · CIK 0001942639 · CEO, PSS Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,102 F3 · kind: Grant of RSUs that vest in three equal annual installments beginning on August 15, 2025. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:15 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 9,918 | $106.36 | $1,054,878.48 |
DisclosureSEC source: 0000721371-24-000073 · wk-form4_1724112931.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, PSS Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,572 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 8,643 restricted share units ("RSUs") and 13,926 performance share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| August 13, 2024 Filed Aug 14, 2024 20:29 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 13,926 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-24-000070 · wk-form4_1723667339.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, PSS Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,490 F1 · kind: Reflects performance share units that will settle on August 15, 2024. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:42 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 638 | $107.08 | $68,317.04 |
DisclosureSEC source: 0000721371-23-000114 · wk-form4_1701812542.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,564 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 14:14 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,373 | $0.00 Strike: $66.43 | $0.00 |
DisclosureSEC source: 0000721371-23-000112 · wk-form4_1701267277.xml · derivative · entry 7 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 15,373 shares Expires 2027-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Stock option vested in three equal installments on August 15, 2018, August 15, 2019, and August 15, 2020. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 14:14 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,279 | $0.00 Strike: $83.19 | $0.00 |
DisclosureSEC source: 0000721371-23-000112 · wk-form4_1701267277.xml · derivative · entry 6 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 6,279 shares Expires 2026-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock option vested in three equal installments on August 15, 2017, August 15, 2018, and August 15, 2019. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 14:14 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,990 | $0.00 Strike: $84.27 | $0.00 |
DisclosureSEC source: 0000721371-23-000112 · wk-form4_1701267277.xml · derivative · entry 5 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 5,990 shares Expires 2025-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vested in three equal installments on August 15, 2016, August 15, 2017, and August 15, 2018. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 14:14 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 36,642 | $106.31 | $3,895,411.02 |
DisclosureSEC source: 0000721371-23-000112 · wk-form4_1701267277.xml · nonDerivative · entry 4 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,202 F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2023. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.11 to $106.76, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 14:14 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Exercise / conversionCommon Shares | 15,373 | $66.43 | $1,021,228.39 |
DisclosureSEC source: 0000721371-23-000112 · wk-form4_1701267277.xml · nonDerivative · entry 3 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2023. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 14:14 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Exercise / conversionCommon Shares | 6,279 | $83.19 | $522,350.01 |
DisclosureSEC source: 0000721371-23-000112 · wk-form4_1701267277.xml · nonDerivative · entry 2 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2023. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 14:14 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Exercise / conversionCommon Shares | 5,990 | $84.27 | $504,777.30 |
DisclosureSEC source: 0000721371-23-000112 · wk-form4_1701267277.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2023. Read SEC document |
| August 28, 2023 Filed Aug 29, 2023 20:21 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,712 | $0.00 Strike: $71.43 | $0.00 |
DisclosureSEC source: 0000721371-23-000082 · wf-form4_169334045113732.xml · derivative · entry 3 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 6,712 shares Expires 2024-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock option vested in three equal installments on August 15, 2015, August 15, 2016, and August 15, 2017. Read SEC document |
| August 28, 2023 Filed Aug 29, 2023 20:21 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 6,712 | $89.81 | $602,804.72 |
DisclosureSEC source: 0000721371-23-000082 · wf-form4_169334045113732.xml · nonDerivative · entry 2 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,202 Read SEC document |
| August 28, 2023 Filed Aug 29, 2023 20:21 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Exercise / conversionCommon Shares | 6,712 | $71.43 | $479,438.16 |
DisclosureSEC source: 0000721371-23-000082 · wf-form4_169334045113732.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 23:51 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 15,487 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000070 · wf-form4_169231625163130.xml · nonDerivative · entry 2 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,202 F3 · kind: Grant of RSUs that vest in three equal annual installments beginning on August 15, 2024. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 23:51 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 10,966 | $92.99 | $1,019,728.34 |
DisclosureSEC source: 0000721371-23-000070 · wf-form4_169231625163130.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,715 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 11,908 restricted share units ("RSUs") and 12,760 performance share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| August 07, 2023 Filed Aug 8, 2023 23:42 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 12,760 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000048 · wf-form4_169153814884060.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,681 F1 · kind: Reflects performance share units that will settle on August 15, 2023. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:29 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 380 | $80.17 | $30,464.60 |
DisclosureSEC source: 0000721371-22-000176 · wf-form4_167027574558242.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,921 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.